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Introduction
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused 
by reactivation of JC virus affecting typically subcortical and periventricular white matter 
of immunocompromised hosts (HIV infection, hematologic malignancies). Cerebral 
hemispheric white matter are most commonly affected by lytic infection, leading to 
progressive damage to oligodendrocytes in the CNS. Neuroimaging usually highlights 
scattered foci of white matter hypodensity not attributable to contrast enhancement or mass 
effect. In contrast, we present an unusual case of PML predominantly affecting cervical 
spinal cord and brainstem in an immunocompetent host. This is a rare subset of PML case 
that can occur in association with connective tissue disorders (Sjögren in this case), SLE 
being the most common. PML should be considered in the differential diagnosis of spinal 
cord/brainstem lesions, particularly in the patients with connective tissue disorders.
Case Presentation and Management
Discussion
References
A 65-year-old female with known history of Sjögren syndrome and liver cirrhosis presented 
to Emergency department with a broken ankle secondary to a four-month-old fall. She also 
reported a four-week history of vertigo, hemiparesis and right sided weakness. 
On examination, she was minimally responsive and obtunded. Her speech was slurred with a 
right facial droop with no cough and gag reflex. There was absent and reduced muscle tone in 
the right extremities and left upper extremity respectively. 
Laboratory test showed high ammonia levels (47umol/L), with abnormal liver enzymes and 
kidney function tests. Cerebrospinal analysis was suggestive of a traumatic tap. 
Immunoglobin G antibodies to SSA/Ro, SSB/La were positive. Thyroglobulin antibodies and 
Anti-nuclear antibodies were elevated. 
MRI of the spine without contrast showed T2 signal abnormality involving the medulla 
extending into the upper cervical cord to C2-C3 level with C3 medullary lesions. Patient 
continued to clinically deteriorate, expiring eight days later.
At autopsy, gross examination of the brain revealed unremarkable cerebral hemispheres, 
sinuses and spinal cord. Histological examination was suggestive of multifocal white matter 
lesions in the cervical spinal cord, pons, medulla, mid brain, cerebellum and basal ganglia. 
These lesions were characterized by pallor, edema, perivascular lymphocytic cuffing, 
microglial nodules, influx of activated microglial and numerous oligodendroglial nuclei with 
ground glass inclusions. The inclusions were immunoreactive with Simian virus-40 (SV-40), 
highlighted by P53 and MIB-1 immunostains. Other areas showed moderate hypoxic 
ischemic changes in the neocortex and hippocampus. These findings supported a diagnosis of 
PML with moderate hypoxic ischemic changes.
Progressive multifocal leukoencephalopathy is an opportunistic demyelinating disease of the 
central nervous system (CNS) caused by reactivation of the DNA viruses of the polyoma 
group. It is caused by one of two polyomavirus, John Cunningham virus (JVC). The disease 
predominantly affects immunocompromised hosts, including people with leukemia, HIV-1 
infection, lymphomas and renal transplant. 
JC virus seropositivity has been demonstrated in approximately 33%-90% of people 
depending on the study and geographical location. Inciting factors to the development of 
PML are the possibility of transformation of a large proportion of lymphocytes which 
become unable to participate in immune responses and therapy induced immunodeficiency.
Patient with autoimmune conditions such as systemic lupus erythematosus, sarcoidosis, 
rheumatoid arthritis and Sjögren's disease independent of immunotherapy could develop 
PML due to disease associated lymphopenia. Although 5.2% of Sjögren syndrome have 
CD4+ T-lymphocytopenia, to our knowledge, only one case of PML has been reported in a 
patient with known history of the disease. 
The pathophysiology could be attributed to leukocyte sequestration in enlarged spleen 
arising from portal hypertension from hepatic cirrhosis leading to patients developing 
leucopenia. In addition, hypogammoglobinemia sequel to liver cirrhosis contributes to 
decreased immunity. 
This case highlights that although PML has been documented in immunocompromised 
patients, it has rarely been associated with connective tissue disorders. Awareness of this 
entity is crucial for pathologists as well as physicians to consider it as differential diagnosis 
of white matter lesions irrespective of the sites of neuraxial involvement. 
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Figure 2 and 3.  H&E stains  highlighting JC virus inclusion s (red arrows) and  
unremarkable oligodendrocytes (blue arrow).
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Figure 1. MRI of the spine without contrast. Arrow shows T2 abnormality involving 
the medulla extending into the upper cervical cord to C2-C3 level.
Figure 2: H&E stain x10 Figure 3: H&E stain x20
Figure 4: SV-40 highlighting JC virus 
inclusions
Figure 5: CD 163 highlighting 
perivascular monocyte/macrophage
